Discovery of natural MCL1 inhibitors using pharmacophore modelling, QSAR, docking, ADMET, molecular dynamics, and DFT analysis

Related articles

1. Computational and Structure-Guided E-Pharmacophore-Based Virtual Screening for the Identification of Novel NEK2 Kinase Inhibitors as Potential Anticancer Agents

   This article has 4 authors:

   1. Hafiz Muzzammel Rehman
   2. Ayesha Latif
   3. Hafiz Muhammad Hammad
   4. Muhammad Sajjad

2. In silico engineered multitarget-directed ligands for the polypharmaceutical treatment of PTEN loss of function endometrial adenocarcinoma

   This article has 18 authors:

   1. Ritchie Delara
   2. Vaidehi Mujumdar
   3. Qi Zhang
   4. Hailey Dryden
   5. Erin Crane
   6. Jubilee Brown
   7. Wendel Naumann
   8. Allison Puechl
   9. David Foureau
   10. Wei Sha
   11. Jessica LeGrand
   12. Hsih Te Yang
   13. Karl Dykema
   14. Bharath Yada
   15. Cody C. McHale
   16. Krishnaiah Maddeboina
   17. Dhananjaya Pal
   18. Donald L. Durden

3. AI-Driven Computational Design of Peptide-Based WWP1 Inhibitors as Promising Therapeutic Agents Against Breast Cancer, Including Triple-Negative Subtype

   This article has 17 authors:

   1. Enrico Mario Alessandro Fassi
   2. Sara Mathlouthi
   3. Elena Maspero
   4. Edoardo Sisti
   5. Giulia Tamboia
   6. Giuseppe De Vita
   7. Fabio Forlani
   8. Simona Polo
   9. Alessandro Gori
   10. Kaliroi Peqini
   11. Sara Pellegrino
   12. Gabriella Roda
   13. Jacopo Sgrignani
   14. Andrea Cavalli
   15. Luisa De Cola
   16. Mariangela Garofalo
   17. Giovanni Grazioso